Cardinal Health, Inc. CAH
252.94 USD -1.39 (-0.55%)
At closeNov 4, 2026, 7:31 AM EST
258.00 +5.06 +2.00%
Pre-market · Nov 4, 7:31 AM ET
252.93 Day range 256.51
180.45 52-week range 259.84
- YTD
- +23.09%
- 1 year
- +32.97%
Analyst view
Consensus: buy
Buy
Price target (mean) 274.87 +8.7% upside
Now 252.94
- Target (low)
- 235.00
- Target (mean)
- 274.87
- Target (high)
- 295.00
Ratings (0m) 17 14 buy · 3 hold · 0 sell
- Strong buy3
- Buy11
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 18
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.94 | 2.88 – 3.06 | 2.55 | +15.3% | 66.51B | +3.9% | 13 |
| Next quarter | 3.13 | 3.07 – 3.37 | 2.63 | +19.0% | 68.29B | +4.0% | 13 |
| Current year | 12.56 | 12.51 – 12.74 | 10.95 | +14.8% | 265.77B | +4.5% | 17 |
| Next year | 14.06 | 13.15 – 14.90 | 12.56 | +11.9% | 281.85B | +6.1% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 20, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 16, 2026 | UBS | Maintained | Buy | Buy |
| Aug 19, 2026 | RBC Capital | Initiated | — | Outperform |
| Aug 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 12, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 12, 2026 | UBS | Maintained | Buy | Buy |
| Aug 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 23, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 20, 2026 | UBS | Maintained | Buy | Buy |
| Jul 9, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 2, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 4, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 1, 2026 | Citigroup | Maintained | Buy | Buy |
| May 1, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 1, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 28, 2026 | William Blair | Initiated | — | Outperform |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 10, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 10, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jan 29, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
